Recognising acute kidney injury

This article has a correction. Please see:
Key points
Even small changes in serum creatinine are associated with poorer outcomes
Risk factors for acute kidney injury (AKI) should be recognised and modified rapidly
Adequate physiological surveillance must be in place for all patients with AKI
The underlying condition should be treated to maximise the chance of improving the AKI
Investigations of a patient with AKI should include urinalysis and renal ultrasound (when obstruction is a possibility)
While it is often possible to identify the sick patient who is clinically dehydrated, hypotensive or septic, a diagnosis of acute renal failure (ARF) or acute kidney injury (AKI) would often not be considered until the results of the urea and electrolytes were obtained. It was felt that seemingly small changes in serum urea and creatinine were unlikely to be associated with any significant changes in outcome, so there was less urgency in making a diagnosis and instituting aggressive therapy. Within the last decade, however, it has been demonstrated that these seemingly small changes in serum creatinine are associated with significant increases in risk for the patient.
Furthermore, it has become increasingly apparent that the previous perception that patients who had ARF would usually recover completely is wrong. There is mounting evidence that patients who have suffered AKI are at far greater risk of progressing to chronic kidney disease (CKD). For this reason, greater emphasis is now placed on the rapid identification and amelioration of risks for AKI, with aggressive treatment of the underlying cause.1
Definitions and staging
A collaborative network of international experts representing nephrology and intensive care societies established the Acute Dialysis Quality Initiative (ADQI), and devised the RIFLE definition and staging system for AKI.2 In this classification AKI is categorised according to the criteria of Risk, Injury, Failure, Loss and End-stage disease for kidneys.
Risk: glomerular filtration rate (GFR) decrease greater than 25%, serum creatinine increase 1.5 times or urine production less than 0.5 ml/kg/hr for six hours.
Injury: GFR decrease above 50%, doubling of creatinine or urine production less than 0.5 ml/kg/hr for 12 hours.
Failure: GFR decrease above 75%, tripling of creatinine or creatinine greater than 355 μmol/l (or urine output below 0.3 ml/kg/hr for 24 hr).
Loss: persistent AKI or complete loss of kidney function for more than four weeks.
End-stage renal disease: complete loss of kidney function for more than three months.
Subsequently, many of the original members of the ADQI group collaborated to form the Acute Kidney Injury Network (AKIN).3 This group modified the RIFLE staging system to reflect the clinical significance of relatively small rises in serum creatinine. More recently, the international guideline group, Kidney Disease: Improving Global Outcomes (KDIGO), has produced a definition and staging system that harmonises the previous definitions and staging systems by both ADQI and AKIN. In this system, stage 1 (or ‘Risk’ stage) AKI is defined as:
serum creatinine increase by at least 26 μmol/l within 48 hours or
serum creatinine rise 1.5 fold or more from the reference value (this should be the lowest value recorded within three months of the event), which is known or
the change in renal function is presumed to have occurred within one week or
urine output less than 0.5 ml/kg/hr for more than six consecutive hours.
Causes of acute kidney injury
AKI is common among hospitalised patients.4,5 It affects at least 3–7% of patients admitted to hospital and approximately 25–30% of patients in the intensive care unit (ICU). Although the terminology for the acute decline of renal function has changed, the mechanisms underlying the deterioration have not. The old separation of prerenal, renal and postrenal causes remains relevant.
Prerenal
Prerenal causes of AKI, which decrease effective blood flow to the kidneys, include low blood volume, low blood pressure and heart failure, as well as local changes to the blood vessels supplying the kidney – the latter include renal artery stenosis and renal vein thrombosis.
Renal
Renal or intrinsic AKI can be due to damage to the glomeruli, renal tubules or interstitium. Common causes of each are glomerulonephritis, so-called acute tubular necrosis and acute interstitial nephritis.
Postrenal
Postrenal AKI is a consequence of urinary tract obstruction that may be related to benign prostatic hyperplasia, kidney stones, obstructed urinary catheter, bladder stone, or bladder, ureteral or renal malignancy. This term may also be applied to the intrarenal obstruction associated with abnormal protein deposition in the tubules, for example as occurs with myeloma.
Practical application of definitions of acute kidney injury
What do the above definitions and classifications mean in practice? A recent National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report6 identified many deficiencies in the care of patients at risk of and suffering from AKI (the report's recommendations are shown in Table 1).
Recommendations from the NCEPOD report.6
In assessing risk, it is important to realise that most AKI is associated with ischaemia, sepsis or nephrotoxic insults. Studies have identified the risk factors most pertinent for the development of AKI:
age over 75 years
CKD (eGFR (electronic glomerular filtration rate) <60 ml/min/1.73 m2)
cardiac failure
atherosclerotic peripheral vascular disease
liver disease
diabetes mellitus
nephrotoxic medications, especially angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and certain antibiotics.
Patients with these risk factors should be actively assessed for AKI, including a review of the physiological parameters routinely reviewed at the bedside using Early Warning Score systems such as the National Early Warning Scoring System (NEWS). Good assessment at an early stage with institution of active measures can prevent the progression of AKI. This should result in aggressive management of underlying potential precipitating factors including:
reduced fluid intake
increased fluid losses
urinary tract infection (UTI) or obstruction
recent nephrotoxic drug ingestion
sepsis.
Investigations
The recognition of AKI is rarely made from clinical examination alone, although it is fairly easy to predict in elderly patients presenting with sepsis and dehydration. Investigations are very important, ranging from simple bedside tests to the more resource-intensive.
Reagent strip urinalysis
Reagent strip urinalysis is a useful investigation, provided that the results are interpreted carefully and simple abnormalities are not assumed to indicate UTI. Protein values of 3+ and 4+ suggest intrinsic glomerular disease. When positive for blood, such values suggest the presence of red blood cells (>5/high power field). The observation of large numbers of red cells in the presence of proteinuria suggests a glomerular aetiology for AKI. Haematuria may also indicate tumours, infection, calculi or severe renal ischaemia. High numbers of white cells are indicative of infection, glomerulonephritis and interstitial nephritis.
Serum and urinary biochemical estimations remain the most important investigation to reveal AKI. The classic laboratory findings are shown in Table 2 but, as demonstrated above, a change in the serum creatinine is among the most important criteria for the diagnosis of AKI.
Classic laboratory findings in acute kidney injury (AKI).
Ultrasound
A critical investigation for the presence of an obstructive uropathy is ultrasound, although in the early stages of obstruction, or in the dehydrated patient, typical hydronephrosis/hydroureter may not be seen even when obstruction is present.
Treatment
Treatment of AKI is aimed at the underlying cause, but a mainstay is adequacy of fluid replacement. It is important that fluid resuscitation provides adequate filling of the intravascular volume, although over-replacement is also associated with an adverse outcome. Treatment of infection, removal of nephrotoxins, relief of obstruction and specific treatment of the renal insult (eg immunosuppression for vasculitides) may all be pertinent. Adequacy of treatment in the early stages of AKI means that most patients will not require active renal intervention in the form of renal replacement therapy (RRT). Often there is more than one precipitating factor; therefore clinicians must adopt a holistic approach to the assessment and management of AKI.
Outcomes
Patients who develop AKI which requires RRT in an ICU have a very high risk of mortality (50–90%), increasing with failure of each additional organ system. Studies have shown however that an increase of serum creatinine of about 50 μmol/l is associated with a 6.5-fold increased risk of mortality and with a prolonged hospital stay for the survivors. Other factors that affect outcome are:
older age
multiorgan failure (ie with all AKI, the more organs that fail, the worse the prognosis)
oliguria
hypotension
vasopressor support
number of transfusions
non-cavitary surgery.
This early identification and aggressive management of AKI should be a high priority so that the patients’ condition can be improved without the use of RRT if at all possible.
Developments
Recognition of AKI depends on measurement of the serum creatinine, as noted above, but an increase in this marker is often a relatively late manifestation of AKI. To improve present systems, many hospitals are introducing electronic alerts that ensure clinicians are rapidly informed by the laboratory staff of changes in the serum biochemistry, so that active intervention for the patient is not delayed.
Furthermore, the development of assays for more sensitive biomarkers has been proposed.7 One such marker, neutrophil gelatinase-associated lipocalin (NGAL), has been demonstrated to be increased in the serum of patients suffering from `renal stress’, including AKI, before more conventional markers, including serum creatinine change.8 Such early recognition could allow earlier intervention and thus improved outcomes from AKI.
- © 2012 Royal College of Physicians
References
- ↵
- ↵
- Bellomo R,
- Ronco C,
- Kellum JA,
- Mehta RL,
- Palevsky P
- ↵
- ↵
- Metcalfe W,
- Simpson KM,
- Khan IH,
- et al
- ↵
- ↵National Confidential Enquiry into Patient Outcome and Death. Acute Kidney Injury: Adding Insult to Injury, 2009 2009 London NCEPOD
- ↵
- Haase M,
- Bellomo R,
- Haase-Fielitz A
- ↵
Article Tools
Citation Manager Formats
Jump to section
Related Articles
Cited By...
- No citing articles found.